AstraZeneca Said to Pay $55 Million Over Seroquel

AstraZeneca Plc, the U.K.’s second- biggest drugmaker, agreed to pay about $55 million to settle around 5,500 lawsuits related to side effects of the antipsychotic Seroquel, people familiar with the accords said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.